- Home
- CZFS vs CRBP Comparison
CZFS vs CRBP Comparison
Compare CZFS & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZFS
- CRBP
- Stock Information
- Founded
- CZFS 1984
- CRBP 2009
- Country
- CZFS United States
- CRBP United States
- Employees
- CZFS N/A
- CRBP N/A
- Industry
- CZFS Major Banks
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- CZFS Finance
- CRBP Health Care
- Exchange
- CZFS Nasdaq
- CRBP Nasdaq
- Market Cap
- CZFS 270.6M
- CRBP 227.3M
- IPO Year
- CZFS N/A
- CRBP N/A
- Fundamental
- Price
- CZFS $72.74
- CRBP $17.47
- Analyst Decision
- CZFS Strong Buy
- CRBP Strong Buy
- Analyst Count
- CZFS 1
- CRBP 7
- Target Price
- CZFS N/A
- CRBP $65.86
- AVG Volume (30 Days)
- CZFS 23.6K
- CRBP 334.8K
- Earning Date
- CZFS 10-30-2024
- CRBP 11-07-2024
- Dividend Yield
- CZFS 2.69%
- CRBP N/A
- EPS Growth
- CZFS 34.84
- CRBP N/A
- EPS
- CZFS 5.75
- CRBP N/A
- Revenue
- CZFS $98,201,000.00
- CRBP N/A
- Revenue This Year
- CZFS N/A
- CRBP N/A
- Revenue Next Year
- CZFS $9.21
- CRBP N/A
- P/E Ratio
- CZFS $12.64
- CRBP N/A
- Revenue Growth
- CZFS 19.13
- CRBP N/A
- 52 Week Low
- CZFS $38.52
- CRBP $4.00
- 52 Week High
- CZFS $74.50
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- CZFS 65.99
- CRBP 42.37
- Support Level
- CZFS $68.05
- CRBP $15.65
- Resistance Level
- CZFS $70.98
- CRBP $17.18
- Average True Range (ATR)
- CZFS 3.41
- CRBP 1.18
- MACD
- CZFS 0.15
- CRBP 0.38
- Stochastic Oscillator
- CZFS 88.97
- CRBP 35.55
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management and retirement services.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.